ANAVEX LIFE SCIENCES CORP. 8-K

What Happened
Anavex Life Sciences Corp. (AVXL) filed an 8-K (Item 8.01) reporting that its Board set September 24, 2026 as the date for the company's 2026 Annual Meeting of Stockholders and July 31, 2026 as the record date for determining which stockholders are entitled to notice of and to vote at the meeting. The company said the time, location and additional details will be included in its definitive proxy statement.

Key Details

• Annual meeting date: September 24, 2026.
• Record date for voting eligibility: July 31, 2026.
• Proxy materials: time/location and other details to be provided in the definitive proxy statement.
• Stockholder proposals/nominations: to be considered timely for inclusion, proposals must be received at the company’s principal executive offices (Anavex Life Sciences Corp., 630 5th Avenue, 20th Floor, New York, NY 10111) on or before July 10, 2026; this reflects the revised deadlines under Rule 14a-5(f) given the meeting date is more than 30 days after last year’s meeting.

Why It Matters
The record date determines which shareholders can vote at the meeting; investors who want to vote must hold shares as of July 31, 2026. Shareholders planning to submit proposals or nominate directors should note the company will treat proposals received by July 10, 2026 as timely for inclusion in the proxy materials—missing these deadlines may prevent inclusion or nomination. The definitive proxy will provide the full details investors need to participate.